S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:HARP

Harpoon Therapeutics News Headlines

$23.40
+2.04 (+9.55 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$21.33
Now: $23.40
$24.75
50-Day Range
$12.83
MA: $16.34
$22.07
52-Week Range
$10.27
Now: $23.40
$25.02
Volume16,268 shs
Average Volume479,380 shs
Market Capitalization$593.89 million
P/E RatioN/A
Dividend YieldN/A
Beta0.87

Headlines

Harpoon Therapeutics (NASDAQ HARP) News Headlines Today

Source:
SourceHeadline
Harpoon Therapeutics (NASDAQ:HARP) vs. Beam Therapeutics (NASDAQ:BEAM) Critical ReviewHarpoon Therapeutics (NASDAQ:HARP) vs. Beam Therapeutics (NASDAQ:BEAM) Critical Review
americanbankingnews.com - January 18 at 12:00 AM
Harpoon Therapeutics (NASDAQ:HARP) Shares Up 9.6%Harpoon Therapeutics (NASDAQ:HARP) Shares Up 9.6%
americanbankingnews.com - January 15 at 6:52 PM
Harpoon Therapeutics Sees Unusually High Options Volume (NASDAQ:HARP)Harpoon Therapeutics Sees Unusually High Options Volume (NASDAQ:HARP)
americanbankingnews.com - January 14 at 9:14 AM
Harpoon Therapeutics, Inc. (NASDAQ:HARP) Receives Consensus Rating of "Buy" from AnalystsHarpoon Therapeutics, Inc. (NASDAQ:HARP) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - January 13 at 7:08 AM
Have Insiders Been Buying Harpoon Therapeutics, Inc. (NASDAQ:HARP) Shares?Have Insiders Been Buying Harpoon Therapeutics, Inc. (NASDAQ:HARP) Shares?
finance.yahoo.com - January 12 at 8:46 AM
Harpoon announces closing of public offeringHarpoon announces closing of public offering
finanznachrichten.de - January 12 at 3:45 AM
Harpoon Therapeutics Announces Closing of Public Offering of Common StockHarpoon Therapeutics Announces Closing of Public Offering of Common Stock
finance.yahoo.com - January 11 at 5:43 PM
Harpoon (HARP) in Focus: Stock Moves 5.6% HigherHarpoon (HARP) in Focus: Stock Moves 5.6% Higher
finance.yahoo.com - January 11 at 12:42 PM
Harpoon Therapeutics Announces Pricing of Public Offering of Common StockHarpoon Therapeutics Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 7 at 1:01 AM
Holger Wesche Sells 10,000 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP) StockHolger Wesche Sells 10,000 Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock
americanbankingnews.com - January 6 at 8:56 PM
Harpoon Therapeutics Announces Proposed Public Offering of Common StockHarpoon Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 6 at 7:53 PM
SVB Leerink Equities Analysts Increase Earnings Estimates for Harpoon Therapeutics, Inc. (NASDAQ:HARP)SVB Leerink Equities Analysts Increase Earnings Estimates for Harpoon Therapeutics, Inc. (NASDAQ:HARP)
americanbankingnews.com - January 6 at 8:26 AM
Q4 2021 Earnings Estimate for Harpoon Therapeutics, Inc. (NASDAQ:HARP) Issued By SVB LeerinkQ4 2021 Earnings Estimate for Harpoon Therapeutics, Inc. (NASDAQ:HARP) Issued By SVB Leerink
americanbankingnews.com - January 5 at 7:28 AM
Harpoon Therapeutics (NASDAQ:HARP) Trading 17.1% Higher  After Analyst UpgradeHarpoon Therapeutics (NASDAQ:HARP) Trading 17.1% Higher After Analyst Upgrade
americanbankingnews.com - January 4 at 7:24 PM
Harpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated TumorsHarpoon Therapeutics Doses First Patient with HPN328, an Anti-DLL3 T Cell Engager for Treatment of Small Cell Lung Cancer and other DLL3-Associated Tumors
finance.yahoo.com - January 4 at 7:56 AM
Harpoon Therapeutics (NASDAQ:HARP) Given New $31.00 Price Target at SVB LeerinkHarpoon Therapeutics (NASDAQ:HARP) Given New $31.00 Price Target at SVB Leerink
americanbankingnews.com - January 4 at 7:52 AM
Stock Traders Buy High Volume of Harpoon Therapeutics Call Options (NASDAQ:HARP)Stock Traders Buy High Volume of Harpoon Therapeutics Call Options (NASDAQ:HARP)
americanbankingnews.com - December 24 at 7:14 AM
Where Do Hedge Funds Stand On Harpoon Therapeutics, Inc. (HARP)?Where Do Hedge Funds Stand On Harpoon Therapeutics, Inc. (HARP)?
finance.yahoo.com - December 12 at 12:12 AM
Harpoon reports clinical progress across all -2-Harpoon reports clinical progress across all -2-
finanznachrichten.de - December 9 at 8:32 PM
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development ProgramsHarpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development Programs
finance.yahoo.com - December 8 at 1:33 PM
Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020
finance.yahoo.com - December 7 at 8:39 PM
Harpoon Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare ConferenceHarpoon Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
finance.yahoo.com - November 16 at 8:42 AM
Harpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual MeetingHarpoon Therapeutics Presents Encouraging Preclinical Data for HPN601 EpCAM ProTriTAC™ Program at 35th SITC Annual Meeting
finance.yahoo.com - November 12 at 8:19 PM
Harpoon Therapeutics, Inc. (NASDAQ:HARP) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportHarpoon Therapeutics, Inc. (NASDAQ:HARP) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
nasdaq.com - November 6 at 10:16 AM
Harpoon Therapeutics, Inc. (NASDAQ:HARP) Analysts Are Cutting Their Estimates: Heres What You Need To KnowHarpoon Therapeutics, Inc. (NASDAQ:HARP) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 6 at 10:16 AM
Harpoon Therapeutics Abstract for HPN601 EpCAM ProTriTAC™ Program Accepted for Oral Presentation at Upcoming 35th SITC Annual MeetingHarpoon Therapeutics Abstract for HPN601 EpCAM ProTriTAC™ Program Accepted for Oral Presentation at Upcoming 35th SITC Annual Meeting
finance.yahoo.com - November 5 at 12:28 PM
Harpoon Therapeutics (NASDAQ:HARP) Shareholders Have Enjoyed A 15% Share Price GainHarpoon Therapeutics (NASDAQ:HARP) Shareholders Have Enjoyed A 15% Share Price Gain
finance.yahoo.com - October 21 at 12:39 PM
Harpoon Therapeutics, Inc. (HARP)Harpoon Therapeutics, Inc. (HARP)
finance.yahoo.com - October 1 at 12:25 AM
Harpoon Therapeutics to Participate in the Cantor Virtual Global Healthcare ConferenceHarpoon Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 9 at 5:13 PM
Harpoon Therapeutics EPS misses by $0.01, misses on revenueHarpoon Therapeutics EPS misses by $0.01, misses on revenue
seekingalpha.com - August 5 at 8:45 PM
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 5 at 8:45 PM
Insider Buys Harpoon Therapeutics's SharesInsider Buys Harpoon Therapeutics's Shares
finance.yahoo.com - August 4 at 6:31 PM
Insider Buys Harpoon Therapeuticss SharesInsider Buys Harpoon Therapeutics's Shares
benzinga.com - August 4 at 1:31 PM
What Type Of Shareholders Make Up Harpoon Therapeutics, Inc.s (NASDAQ:HARP) Share Registry?What Type Of Shareholders Make Up Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Share Registry?
finance.yahoo.com - July 23 at 1:09 PM
What Type Of Shareholders Make Up Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Share Registry?What Type Of Shareholders Make Up Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Share Registry?
finance.yahoo.com - July 23 at 1:09 PM
Hedge Funds Are Warming Up To Harpoon Therapeutics, Inc. (HARP)Hedge Funds Are Warming Up To Harpoon Therapeutics, Inc. (HARP)
finance.yahoo.com - July 5 at 7:34 PM
BRIEF-Harpoon Therapeutics Reports Changes To Board Of DirectorsBRIEF-Harpoon Therapeutics Reports Changes To Board Of Directors
www.reuters.com - July 2 at 11:45 PM
Harpoon Therapeutics to Participate in Two Upcoming Virtual ConferencesHarpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
finance.yahoo.com - June 11 at 8:09 AM
Harpoon Therapeutics (HARP) Presents At ASCO 2020 - SlideshowHarpoon Therapeutics (HARP) Presents At ASCO 2020 - Slideshow
seekingalpha.com - May 29 at 5:30 PM
BRIEF-Harpoon Therapeutics Presents Interim Phase 1 Data From An Ongoing Dose Escalation Trial For The Psma-Targeting Tritac® Hpn424BRIEF-Harpoon Therapeutics Presents Interim Phase 1 Data From An Ongoing Dose Escalation Trial For The Psma-Targeting Tritac® Hpn424
www.reuters.com - May 29 at 12:29 PM
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific ProgramHarpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific Program
finance.yahoo.com - May 29 at 12:29 PM
PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On WatchPHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch
www.nasdaq.com - May 28 at 6:26 AM
Harpoon Therapeutics to Present Interim Clinical Data for TriTAC® HPN424 at the ASCO20 Virtual Scientific ProgramHarpoon Therapeutics to Present Interim Clinical Data for TriTAC® HPN424 at the ASCO20 Virtual Scientific Program
finance.yahoo.com - May 22 at 9:47 AM
Analysts Are Much More Bearish On Harpoon Therapeutics, Inc. (NASDAQ:HARP) Than They Used To BeAnalysts Are Much More Bearish On Harpoon Therapeutics, Inc. (NASDAQ:HARP) Than They Used To Be
finance.yahoo.com - May 11 at 8:53 AM
Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate UpdateHarpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 7 at 6:41 PM
Harpoon Therapeutics up 9% on launch of HPN217 study in multiple myelomaHarpoon Therapeutics up 9% on launch of HPN217 study in multiple myeloma
seekingalpha.com - April 27 at 4:37 PM
BRIEF-Harpoon Therapeutics Doses First Patient With HPN217 For Multiple MyelomaBRIEF-Harpoon Therapeutics Doses First Patient With HPN217 For Multiple Myeloma
www.reuters.com - April 27 at 8:08 AM
Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple MyelomaHarpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma
finance.yahoo.com - April 27 at 8:08 AM
Companies Like Harpoon Therapeutics (NASDAQ:HARP) Can Afford To Invest In GrowthCompanies Like Harpoon Therapeutics (NASDAQ:HARP) Can Afford To Invest In Growth
finance.yahoo.com - March 26 at 1:47 PM
Harpoon Therapeutics, Inc. 2019 Q4 - Results - Earnings Call PresentationHarpoon Therapeutics, Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 13 at 3:51 PM
This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.